植入前疾病严重程度对儿童持久性心室辅助装置结局的影响
该研究基于儿科机械循环支持登记系统,分析373例接受持久性VAD的儿童,按INTERMACS分级比较结局。结果显示心源性休克(PP1)患者死亡率最高,机械通气与各分级死亡率升高相关。
要点
- 心源性休克(PP1)患儿VAD植入后6个月内死亡率最高。
- 机械通气使各INTERMACS分级患儿死亡率升高。
- PP1中先心病是独立死亡风险因素。
核心结论
- VAD植入时处于休克的儿童结局较差。
- 即使较低INTERMACS分级,机械通气仍与死亡率增加相关。
研究设计与样本
- 回顾性分析儿科机械循环支持登记系统46个中心373例年龄<19岁接受持久性VAD的患儿。
- 按INTERMACS患者分级和植入前特征,采用竞争风险方法比较结局。
主要发现
- 97例为心源性休克(PP1),222例为进行性恶化(PP2),42例为稳定使用正性肌力药(PP3)。
- 植入后6个月内57%接受移植,14%死亡。
- PP1死亡率最高(25% vs PP2的10%,HR 2.5,95%CI 1.4-4.4,p=0.02)。
- PP1中先心病为独立死亡风险因素(HR 2.9,95%CI 1.1-7.8,p=0.03)。
- PP2中搏动性VAD与死亡相关(HR 3.9,95%CI 1.6-9.5,p=0.003)。
临床怎么用
- 对VAD候选患儿应评估INTERMACS分级及机械通气状态以分层风险。
- 心源性休克合并先心病患儿需更谨慎评估VAD获益与风险。
局限性
- 需进一步研究识别该人群可干预的风险因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Durable ventricular assist devices (VADs) are increasingly used to treat children with heart failure. Studies demonstrate worse outcomes for those in cardiogenic shock at the time of VAD, but limited data exist on less acutely ill children. We describe the association between illness severity and outcomes in this population. METHODS: Data were analyzed from 373 children (aged <19 years) receiving durable VADs from 46 centers in the Pediatric Interagency Registry for Mechanical Circulatory Support. Outcomes were compared by Interagency Registry for Mechanical Circulatory Support (INTERMACS) Patient Profile (PP) and pre-implant characteristics using competing risks methodology. RESULTS: Analyses identified 97 patients in cardiogenic shock (PP 1), 222 with progressive decline (PP 2), and 42 stable on inotropes (PP 3). There were 39 infants, 124 were aged 1 to 9 years and 210 were aged 10 to 19 years. A majority had cardiomyopathy and 66 had congenital heart disease (CHD). There were 224 (62%) continuous-flow VADs. Before implant, 40% received mechanical ventilation (MV). Within 6 months post-implant, 57% underwent transplant and 14% died. PP 1 mortality was highest (25% vs 10% for PP 2, hazard ratio [HR]: 2.5, 95% CI: 1.4-4.4, p = 0.02). In PP 1, CHD was an independent mortality risk factor (HR: 2.9, 95% CI: 1.1-7.8, p = 0.03). In PP 2, pulsatile VADs were associated with death (HR: 3.9, 95% CI: 1.6-9.5, p = 0.003). Patients on MV had high mortality (20%-30%) across PP 1 to PP 3 (HR: 3.0 vs no MV, p < 0.001). CONCLUSIONS: Children in shock at the time of VAD implant have poor outcomes. MV is associated with increased mortality even in lower acuity INTERMACS profiles. Further study is needed to identify modifiable risk factors in this population.
引用
- Butto A, Teele SA, Sleeper LA, et al. The impact of pre-implant illness severity on the outcomes of pediatric patients undergoing durable ventricular assist device. J Heart Lung Transplant. 2020. PMID: 32165048. doi:10.1016/j.healun.2020.02.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。